| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |